Paxil vs Zoloft
Paxil (paroxetine) and Zoloft (sertraline) are both selective serotonin reuptake inhibitors (SSRIs) prescribed for depression, anxiety disorders, OCD, PTSD, and other conditions. Despite sharing the same drug class and overlapping indications, they differ substantially in their tolerability profiles, side effect burden, and ease of discontinuation. These differences have made sertraline the significantly more commonly prescribed of the two in contemporary practice.
Quick Comparison
| Feature | Paxil (Paroxetine) | Zoloft (Sertraline) |
|---|---|---|
| Drug Class | SSRI | SSRI |
| Generic Name | Paroxetine hydrochloride | Sertraline hydrochloride |
| Brand Name | Paxil, Paxil CR, Brisdelle | Zoloft |
| Approved For | MDD, OCD, panic disorder, social anxiety, GAD, PTSD, PMDD (CR), vasomotor symptoms of menopause (Brisdelle) | MDD, OCD, panic disorder, social anxiety, PTSD, PMDD |
| Available as Generic | Yes | Yes |
| Key Advantage | Broad indications; sedating properties useful in anxiety with insomnia; FDA-approved for menopause symptoms | Better tolerated overall; preferred in pregnancy; fewer drug interactions; more commonly prescribed |
| Main Drawback | Worst discontinuation syndrome of any SSRI; significant weight gain; anticholinergic burden; potent CYP2D6 inhibitor | More GI side effects (diarrhea) than some SSRIs; moderate CYP2D6 inhibition |
How They're Similar
Both paroxetine and sertraline block the serotonin transporter (SERT), increasing serotonergic neurotransmission — the core antidepressant and anxiolytic mechanism. Both are effective first- and second-line treatments for depression and a broad range of anxiety disorders, with overlapping FDA-approved indications across MDD, OCD, panic disorder, social anxiety disorder, and PTSD.
Both carry the class-wide black box warning for increased suicidal ideation in children, adolescents, and young adults. Both can cause sexual dysfunction (often the most complained-about long-term side effect), nausea (especially at initiation), and insomnia or sedation depending on the individual. Both are available as inexpensive generics.
Key Differences
Anticholinergic effects: Paroxetine has meaningfully more anticholinergic receptor activity than sertraline or most other SSRIs. This contributes to side effects including dry mouth, constipation, urinary retention, blurred vision, and cognitive blunting — effects that are more clinically relevant in elderly patients, where anticholinergic burden is linked to increased fall risk and cognitive concerns. Sertraline has minimal anticholinergic activity.
Weight gain: Paroxetine is associated with clinically significant weight gain over time — it is consistently ranked among the SSRIs most likely to cause meaningful weight increase. Sertraline is more weight-neutral, though some weight gain can occur with any long-term SSRI use.
Discontinuation syndrome: Paroxetine has the shortest half-life of the commonly used SSRIs (approximately 21 hours) and the most potent self-inhibition of its own metabolism (via CYP2D6), making its blood levels highly sensitive to dose changes. This combination produces the most severe and frequently reported discontinuation syndrome of any SSRI — characterized by electric shock sensations ("brain zaps"), dizziness, flu-like symptoms, irritability, and anxiety upon tapering or missing doses. Tapering paroxetine often requires a very slow, prolonged taper strategy. Sertraline has a longer active metabolite half-life and discontinuation effects, while still present, are generally milder and more manageable.
Drug interactions: Paroxetine is a potent inhibitor of CYP2D6, one of the liver's most important drug-metabolizing enzymes. This can significantly raise blood levels of co-administered drugs metabolized by CYP2D6, including tamoxifen (critically, paroxetine reduces tamoxifen's effectiveness in breast cancer — this combination should generally be avoided), certain antipsychotics, opioids (codeine, tramadol), and tricyclic antidepressants. Sertraline is a moderate CYP2D6 inhibitor and requires attention in polypharmacy but poses less interaction risk than paroxetine.
Pregnancy: Sertraline is generally preferred over paroxetine during pregnancy. Paroxetine has been associated with a small increased risk of cardiac defects (particularly ventricular septal defects) in first-trimester exposure, earning it a Pregnancy Category D designation in older FDA categorizations. Sertraline is the most studied and generally the most recommended SSRI in pregnant populations when pharmacotherapy is necessary.
Menopause symptom approval: Paroxetine (as Brisdelle) has an FDA approval for moderate-to-severe vasomotor symptoms (hot flashes) associated with menopause — making it the only non-hormonal medication with this specific indication that is an antidepressant. Sertraline does not carry this approval.
Paroxetine: Strengths & Weaknesses
Strengths: Paroxetine's mildly sedating properties can be useful in patients with anxiety-driven insomnia. Its broad FDA indication list — including vasomotor symptoms of menopause — provides clinical flexibility. Some patients respond to paroxetine after failing other SSRIs.
Weaknesses: The combination of significant weight gain potential, anticholinergic burden, potent CYP2D6 inhibition, and the most challenging discontinuation syndrome of any SSRI has caused many clinicians to reach for other options first. In patients on tamoxifen for breast cancer, paroxetine should generally be avoided entirely.
Sertraline: Strengths & Weaknesses
Strengths: Sertraline is consistently cited in comparative effectiveness analyses as among the best-tolerated SSRIs, with lower discontinuation rates in clinical trials. Its safety profile in pregnancy is the most favorable among SSRIs. Its moderate (rather than potent) CYP2D6 inhibition makes it easier to use alongside other medications.
Weaknesses: Diarrhea and other GI side effects may be more pronounced with sertraline than with some other SSRIs. It does not offer the sedating benefit that can be useful in highly anxious or sleep-disrupted patients.
Which Is Right for You?
Only your prescriber can make this determination based on your complete medical and medication history. The considerations below reflect common clinical thinking — they are not personal recommendations.
In contemporary clinical practice, sertraline is typically preferred over paroxetine as a first-line SSRI choice due to its better tolerability profile, easier discontinuation, and more favorable pregnancy and drug interaction profile. Paroxetine may still be considered when a patient has previously responded to it, when its mild sedation is seen as a therapeutic benefit, or for the treatment of vasomotor symptoms in menopause.
Frequently Asked Questions
Why is Paxil so hard to stop taking?
Paroxetine has the shortest half-life of the major SSRIs and is a potent inhibitor of its own metabolism through CYP2D6, meaning small dose reductions produce disproportionately large drops in blood levels. This causes rapid, pronounced withdrawal symptoms ("discontinuation syndrome") including brain zaps, dizziness, flu-like feelings, and rebound anxiety. Successful tapering often requires an extended slow taper, sometimes using liquid formulations to make tiny dose reductions.
Which causes more weight gain — Paxil or Zoloft?
Paroxetine consistently causes more weight gain than sertraline in head-to-head comparisons and large observational studies. Some analyses suggest paroxetine is the most weight-promoting SSRI overall. Sertraline is more weight-neutral, though weight changes can occur with any SSRI over long-term use.
Can I switch from Paxil to Zoloft?
Yes, though the switch requires care due to paroxetine's potent CYP2D6 inhibition. When switching, paroxetine's inhibition of CYP2D6 means that sertraline levels (if sertraline is also metabolized via CYP2D6) may initially be higher than expected. Most clinicians perform a gradual cross-taper. The specific approach depends on the doses involved and your prescriber's clinical judgment.
Is Paxil safe during pregnancy?
Paroxetine is generally avoided in pregnancy, particularly in the first trimester, due to an association with a small increased risk of cardiac defects in the newborn. Sertraline is the preferred SSRI when antidepressant treatment is necessary during pregnancy. That said, the decision always involves weighing the risks of untreated illness against medication exposure — this is a conversation to have with your OB-GYN and psychiatrist.
Related Articles
Related Pages
⚠ This comparison is for informational purposes only. Never start, stop, or switch medications without guidance from a licensed healthcare provider. Abruptly stopping paroxetine can cause significant discontinuation symptoms — always taper under medical supervision.